Global Facial Injectable Market
Facial Injectable Market- By Product, Application, and Region.
The Global Facial Injectable Market is valued at USD 4.37 Billion in the year 2022 and is forecasted to reach a value of USD 8.82 Billion by the year 2030. The Global Market is anticipated to grow exhibiting a Compound Annual Growth Rate (CAGR) of 9.20% over the forecast period.
Facial Injectable Market Size, 2022 To 2030 (USD Billion)
Facial injectables are facial skin fillers that are used for a variety of purposes including dark circle reduction, brow lift, lip thinning, cheekbone enlargement, and more. Facial injectables are also used to minimize wrinkles and smooth the appearance of skin that has been affected by age, acne, or scars. Face, including the Nasolabial fold, cheekbones, lips, corners of the eye, and the dorsal area of the hands, are the main application sites. In recent years, there has been an increase in demand for face injectables due to a greater focus on physical attractiveness among consumers. Increased awareness of minimally invasive procedures as a result of different beauty campaigns undertaken by leading industry participants is another factor driving market expansion. Non-surgical market therapies, facial injectable fillers, and wrinkle relaxer injectables have all seen a three-fold increase. During the projection period, non-invasive aesthetic procedures will boost the market. Skin damage is caused by pollution and numerous lifestyle choices, which drive up demand throughout the projection period.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
There is minimal chance of infection, no blood loss, and lower procedural expenses because of technological advancements. The growth of the cosmetic industry has boosted the demand for facial injectables. The need for hyaluronic acid is driving the market for cosmetic injectables. The market is influenced on a significant scale by disposable incomes, expanding social media influence, and growth in the number of professional practitioners and consumers eager to buy organic and biodegradable goods. However, Rashes and redness on the skin, as well as tight regulatory concerns and limits on products, limit expansion. Multiple market stumbling blocks, rather than aesthetic applications, will stymie expansion in the future projected period. Filler prices are too high, limiting expansion and, as a result, market size. The negative effects of dermal injectables are also a major issue limiting the size of the Facial Injectable business.
The Facial Injectable Market is segmented on the basis of Product and Application. On the basis of Product, the market is segmented into Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), and Polymer Fillers. On the basis of Application, the market is segmented into Aesthetics and Therapeutics.
Below tree is interactive. You can click the nodes to get more information.
Based on Product:
On the basis of Product, the market is segmented into Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), and Polymer Fillers. The botulinum toxin type A category, which accounted for the majority of sales in 2021, topped the market. Middle-aged women who seek to counteract the effects of aging are increasingly turning to fillers and injectables like Botox. The Hyaluronic Acid (HA) category is predicted to expand the fastest during the forecast period. It's well-known for its ability to keep moisture in the skin, making it look younger. HA has a moisture-binding property that helps to improve and maintain the vital moisture required for facial plumpness. Cosmetic-grade HA has a low molecular weight, allowing it to penetrate deep into the epidermis, where it holds water in the cells and releases antioxidants to help delay the aging process.
Based on Application:
On the basis of Application, the market is segmented into Aesthetics and Therapeutics. The aesthetics category dominated the market in 2021, accounting for the vast majority of sales. This growth has been spurred by the rising use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines, to name a few. Because of reasons such as growing knowledge of cosmetic operations and rising disposable money, the market is expected to grow. The market is expected to grow due to a rise in the use of facial injectables for parentheses lines, facial wrinkles, lip lines, lip augmentation, lip border restoration, perioral lines, and crow's feet lines. In the future years, demand for facial injectables for cosmetic purposes is predicted to rise due to a growing interest in physical appearance and an increase in disposable income among the middle-class population in developing nations such as India. Over the projection period, the therapeutic segment is expected to grow at a double-digit Compound Annual Growth Rate (CAGR).
North America is projected to acquire the largest market share during the year 2021
North America is projected to acquire the largest market share during the year 2021 with a share of 47.10%. Some of the factors driving market growth in the North American region include increased awareness of aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of key market players, the growing geriatric population, and demand for non-invasive aesthetic procedures. The advantageous reimbursement policies, the regulatory environment, and the availability of advanced medical technology and infrastructure all contribute to the market's growth in this region.
Key players operating in the Global Facial Injectable Market include- Ipsen, Merz Pharma, Suneva Medical Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, Allergan Inc. and others.
Segmentation of the Global Facial Injectable Market:
- Product (Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymer Fillers)
- Application (Aesthetics, Therapeutics)
- Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
|Regions & Countries Covered
- North America - (U.S., Canada, Mexico)
- Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
- Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
- Latin America - (Brazil, Argentina, Rest Of Latin America)
- Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
- Merz Pharma
- Suneva Medical Inc.
- Medytox Inc.
- Sinclair Pharma
- Bloomage BioTechnology Corporation Limited
- Anika Therapeutics Inc.
- Prollenium Medical Technologies
- Allergan Inc.
||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Pricing and purchase options
||Avail of customized purchase options to meet your exact research needs. Explore purchase options